These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 9013399

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of central administration of arginine-vasopressin on aversive memory retrieval.
    Kumar KB, Karanth KS.
    Brain Res; 1995 Nov 20; 699(2):293-6. PubMed ID: 8616633
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role.
    Cador M, Ahmed SH, Koob GF, Le Moal M, Stinus L.
    Brain Res; 1992 Dec 04; 597(2):304-9. PubMed ID: 1473001
    [Abstract] [Full Text] [Related]

  • 11. Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity.
    Diamant M, de Wied D.
    Neuroendocrinology; 1993 Jun 04; 57(6):1071-81. PubMed ID: 8232765
    [Abstract] [Full Text] [Related]

  • 12. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.
    Heinrichs SC, Pich EM, Miczek KA, Britton KT, Koob GF.
    Brain Res; 1992 May 29; 581(2):190-7. PubMed ID: 1327398
    [Abstract] [Full Text] [Related]

  • 13. Effects of p-chlorophenylalanine-induced depletion of brain serotonin on retrieval of appetitive and aversive memories.
    Kumar KB, Nalini K, Karanth KS.
    Indian J Exp Biol; 1995 Nov 29; 33(11):837-40. PubMed ID: 8786157
    [Abstract] [Full Text] [Related]

  • 14. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.
    Britton KT, Lee G, Vale W, Rivier J, Koob GF.
    Brain Res; 1986 Mar 26; 369(1-2):303-6. PubMed ID: 3008937
    [Abstract] [Full Text] [Related]

  • 15. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F, Rubio P, Menzaghi F, Merlo-Pich E, Rivier J, Koob GF, Navarro M.
    J Pharmacol Exp Ther; 1996 Jan 26; 276(1):56-64. PubMed ID: 8558457
    [Abstract] [Full Text] [Related]

  • 16. Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.
    Kask A, Rägo L, Harro J.
    Neuroreport; 1997 Nov 10; 8(16):3645-7. PubMed ID: 9427342
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies.
    Curtis AL, Grigoriadis DE, Page ME, Rivier J, Valentino RJ.
    J Pharmacol Exp Ther; 1994 Jan 10; 268(1):359-65. PubMed ID: 8301577
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.